Screener
Viridian Therapeutics, Inc. VRDN PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Other receivable | 75,000 | — |
| Prepaid expenses and other current assets | 24,740 | 19,581 |
| Total current assets | 1,081,270 | 894,233 |
| Property and equipment, net | 2,765 | 1,228 |
| Operating lease right-of-use asset | 2,085 | 2,421 |
| Intangible asset, net | 10,000 | — |
| Other assets | 1,113 | 1,536 |
| Total assets | $1,097,233 | $899,418 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s PP&E (net)?
- Viridian Therapeutics, Inc. (VRDN) reported PP&E (net) of $2.77M in Q2 2026.
- How has Viridian Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Viridian Therapeutics, Inc.'s PP&E (net) increased by 153.4% year-over-year, from $1.09M to $2.77M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s PP&E (net) has grown at a 31.8% compound annual growth rate (CAGR), from $309K to $1.23M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Viridian Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude